Peer Review History

Original SubmissionMarch 28, 2022
Decision Letter - Simone Borsci, Editor

PONE-D-22-09068Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.PLOS ONE

Dear Dr. Toll,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 30 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Simone Borsci, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

 “This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 “This research was supported by the Australian Government Department of Health and the Digital Health CRC Limited (DHCRC). DHCRC is funded under the Commonwealth’s Cooperative Research Centres (CRC) Program.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Additional Editor Comments :

Dear Authors, the comments of the Reviewers are overall positive. Nevertheless, one of the reviewers provided a list of critical points that need to be adjusted to ensure the replicability of the study.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. The inclusion of minority groups in this study is key a strength. Could you elaborate if conducting a focus group in a language other than English was intended?

2. What were the experiences of the CALD group in accessing telehealth and were there barriers due to language? Could you elaborate on whether telehealth was conducted with clinicians that spoke the same language as participants or with interpreters or caregivers?

3. It is noted that face-to-face consultations were preferred by participants when physical examinations were required. Was there any evidence of physical examinations being conducted via videoconference? Did participants find this of value and did they feel prepared and comfortable to undertake this in their homes?

4. Is it worth commenting on the under representation of men as a study limitation?

5. Minor typographical errors for review. Line 66: 'response' spelt incorrectly. Lines 72-76: sentence is difficult to read and would be helped if simplified? Line 167: missing 'to' after responses? Lines 211-213: colon after Sydney should be a semicolon or comma? Line 227: missing closed bracket after physiotherapy?

Reviewer #2: Thank you for asking me to review this manuscript. I would firstly like to congratulate the authors on an interesting and timely study. Given the proliferation of telehealth, capturing the consumer experience of telehealth during the COVID pandemic, is indeed a useful exercise.

I do have some suggestions for further improvement of the manuscript:

• Research methodology - Within qualitative, there are number of methodologies (grounded theory, phenomenology, ethnography etc). What is the qualitative methodology for this study?

• Kitchen Table Discussion – I have not heard of this before but sounds very interesting. Why was this chosen as the method of data collection? Has this been tried before in other similar research?

• Sampling – How were the participants identified and recruited? There is no reference in this section. Sampling framework needs more details and references.

• Recruitment – There are two groups here from what I understand. There are the “hosts” and “participants”. It would be good to break the recruitment strategies into these two groups and report it as such. For example, how did the hosts source the contact details of the participants? How did the researchers ensure there was enough coverage of participants? If the host and participants were social acquaintances, how was coercion avoided?

• Data collection – So the hosts recorded participant responses each question onto template and then it was audiorecorded and transcribed? Is that right? If so, why did you collect the same data in two different ways?

• Who did the transcription of the interviews?

• How was observation data managed?

• Rigour –It would be useful to outline clearly the strategies used and how this contributed to the rigour of the data collection and analysis. This is not clearly articulated.

• Data collection –Was there any follow up to clarify any issues? How did member checking actually occur? Again, there needs to be references here to defend your choice.

• Sample size – how was sample size determined?

• Sometimes you use the word “interview” and sometimes it is focus group. Please be consistent.

• How did you ensure rigour and trustworthiness?

• “The interviews opened by asking respondents about the modality of telehealth services and which if any services are preferred for telehealth” – this is Method right? Not results.

• “Telehealth consults were provided across the public, private and community services sector, with the majority conducted over the phone.” – where is the data to back this up in text?

• For each quote, it is important to provide some information about the person who reported it. You could include a pseudonym or other characteristic as it would add weight to your results and show the reader who said what.

• Need a section on limitations.

• Implications for practice and research – Based on the findings from this research, what are the implications for practice and research?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear the Editor and Reviewers,

We, the authors, would like to thank both the Editor and Reviewers for the time taken to thoroughly review and provide feedback to our manuscript. We have found this to be incredibly useful and enabled the manuscript to be developed into a more precise and well-thought through version.

Thank you for the opportunity to make these revisions to our manuscript and resubmit a version that addresses each of the points raised during the review process. The table in the attached "Response to Reviewers" letter shows each point raised by the Editor and each Reviewer, and how we have responded to each point. The line numbers stated are for the marked-up copy of the manuscript, so will differ to the unmarked version.

Thank you again for the invaluable feedback and time given, and for considering our manuscript for the PLOS ONE journal.

Yours sincerely,

Kaylie Toll

On behalf of the authorship team

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Mukhtiar Baig, Editor

PONE-D-22-09068R1Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.PLOS ONE

Dear Dr. Toll,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mukhtiar Baig, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #3: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: The authors have not made all data available (but have explained the reasons for this adequately).

I felt the manuscript was well written and in the main, the previous reviewer comments had been dealt with adequately. Having not seen the manuscript prior to its resubmission following responses to peer review, I have not conducted a full, fresh review, but restrict my comments to the extent to which I feel that previous reviewer comments have been dealt with. I suggest some further minor amendments.

1. Reviewer 2 noted the possibility of coercion if participants were previously known to hosts or were social acquaintances. The authors did not address this point in their response but it is an important one that has bearing on the rigour, reproducibility and credibility of the data, so I would ask that the authors include a specific comment within their methodology on this. It is likely that most of the participants knew the hosts because the hosts took the lead on sampling and recruiting participants from within their networks. Allied to this - what influence (if any) did the researchers have on the diversity of participants that the hosts recruited e.g. was there a sampling frame that hosts were required to use, or did they have complete carte blanche over who they recruited to be in the KTD?

2. It is not clear why the issues with data recording arose in the first place. Usually, if a participant does not consent to being recorded, they are in essence not consenting to the study and ought to take no further part in it. It is strange that the authors chose instead to not record the entire session simply because one individual may not have wanted to be recorded. This may have implications for the quality of data from the sessions that were not recorded, and I would like to see more reflection on this approach (and its potential consequences) in the paper.

3. Whilst the authors have addressed a point about the data analysis process from the perspective of dual coding from a second researcher, the authors did not address the important point from reviewer 2 about member checking e.g. were hosts and/or participants given the transcripts so that they had the opportunity to amend anything they said or withdraw any of their statements? If not, why not?

Similarly, rigour and trustworthiness can be broader than simply having dual review of transcripts/coding (reviewer 2 point 12). I would invite the authors to consider how they ensured rigour/trustworthiness in a broader sense than just in the data analysis stage.

4. The authors chose not to add any information about the person saying a quotation because of the possibility of anonymity being broken. This is a legitimate concern but would actually not preclude the authors adding some very brief information on an individual that would not break participant confidentiality, such as gender, broad age (e.g. under 50, above 50), some sense of urbanity/rurality (given that this is one of the characteristics the authors surmise may make a difference to patient receptiveness to telehealth), or past use of telehealth yes/no. I would maintain that having some information about the person who reported a quotation is still very important, and can be done sensitively without any risk that a participant would be identified from the manuscript. I would ask the authors to reconsider their decision on this point.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Dear the Editor and Reviewers,

We, the authors, would like to thank both the Editor and Reviewers for the time taken to review our previous responses and provide feedback to our manuscript. We have found this to be incredibly useful and enabled the manuscript to be developed into a more precise and well-thought through version.

Thank you for the opportunity to make these revisions to our manuscript and resubmit a version that addresses each of the points raised during the review process. The table below shows each point raised by the Editor and each Reviewer, and how we have responded to each point. The line numbers stated are for the tracked changes copy of the manuscript, so will differ to the unmarked version.

Thank you again for the invaluable feedback and time given, and for considering our manuscript for the PLOS ONE journal.

Yours sincerely,

Kaylie Toll

On behalf of the authorship team

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Mukhtiar Baig, Editor

Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.

PONE-D-22-09068R2

Dear Dr. Toll,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mukhtiar Baig, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

No comments

Reviewers' comments:

Formally Accepted
Acceptance Letter - Mukhtiar Baig, Editor

PONE-D-22-09068R2

Consumer preferences, experiences, and attitudes towards telehealth: qualitative evidence from Australia.

Dear Dr. Toll:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Mukhtiar Baig

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .